Fineotex Chemical has announced its audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026. The Board of Directors, which met on May 15, 2026, approved the results and recommended a final dividend of ₹0.05 per equity share. This dividend is subject to shareholder approval at the upcoming Annual General Meeting. For the financial year, the company reported a total dividend payout of ₹14.99 crore, compared to ₹9.17 crore in the previous year.

Consolidated Financial Performance

The company delivered robust growth in consolidated revenue and profitability for the full year. Revenue from operations for FY26 increased to ₹772.23 crore, a growth of 45% from ₹533.33 crore in FY25. Profit after tax (PAT) for the year rose by 14% to ₹125.01 crore from ₹109.21 crore in the previous year. The consolidated Return on Invested Capital (ROIC) for FY26 stood at 31.10%.

For the fourth quarter (Q4 FY26), revenue surged 162% year-on-year to ₹313.73 crore from ₹119.79 crore in Q4 FY25. PAT for the quarter increased by 118% to ₹43.80 crore from ₹20.13 crore in the corresponding period of the previous year. Operational EBITDA for the quarter grew by 86% to ₹53.15 crore from ₹28.83 crore.

The following table details the consolidated financial performance for the quarter and full year:

Operational and Corporate Updates

The company's volume growth for the consolidated business in Q4 increased by approximately 59% on a quarter-on-quarter basis and 131% on a year-on-year basis. Fineotex Chemical was recognized as a Great Place to Work for the fifth consecutive year. During the year, the Board approved a stock split of equity shares from a face value of ₹2 each to ₹1 each and a bonus issue in the ratio of 4:1. Consequently, the paid-up share capital as of March 31, 2026, stood at ₹11,645.01 lakh.

The statutory auditors, M/s. ASL & Co., Chartered Accountants, have issued an unmodified audit report on the standalone and consolidated financial results.

Management Commentary

In an earnings conference call held on May 18, 2026, management highlighted that the strong Q4 performance was driven by healthy underlying demand across three business segments, along with robust contribution from the newly acquired CrudeChem Technologies Group. International revenue contribution increased significantly to 70% in Q4 FY26. The working capital cycle remains healthy at 79 days.

Management stated that the company is in the process of doubling manufacturing capacity at CrudeChem to cater to larger contracts and accelerate growth in the high-margin specialty oilfield chemicals segment. The company targets a $200 million revenue run rate from the US business by 2028, revised from an earlier estimate of 2030, with EBITDA margins expected to reach 15%. On a consolidated level, the company aims for a blended EBITDA margin of 18% to 20%.

Surendrakumar Tibrewala, acting as a promoter of fineotex chemical Limited, has submitted a formal disclosure to the stock exchanges on April 06, 2026, pursuant to Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeover) Regulations, 2011. The declaration confirms that the promoter and promoter group, along with persons acting in concert, have not made any encumbrance over the shares of the company held by them, either directly or indirectly, during the financial year ended March 31, 2026.

Regulatory Disclosure Under SEBI Takeover Regulations

The disclosure was filed with both BSE Limited and the National Stock Exchange of India Limited, as required under the applicable regulatory framework. Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeover) Regulations, 2011 mandates that promoters and promoter group entities make an annual declaration regarding the encumbrance status of their shareholding. The filing was addressed to the Listing Department of BSE Limited and the Listing & Compliance Department of the National Stock Exchange of India Limited, and a copy was also marked to the Audit Committee and Compliance Officer of Fineotex Chemical Limited.

Promoter and Promoter Group Shareholding Details

As per Annexure – A attached to the disclosure, the promoter and promoter group collectively hold 72,54,90,270 shares, representing 63.32% of the total share capital of the company. The table below provides a detailed breakdown of the shareholding across all members of the promoter group:

The largest individual holding within the promoter group belongs to Surendra Deviprasad Tibrewala, who holds 60,88,57,860 shares, accounting for 53.14% of the total share capital. Corporate entities Kamal Chemicals Pvt Ltd and Proton Biochem Pvt Ltd collectively contribute 2.58% and 0.90% to the promoter group's aggregate stake, respectively.

Filing Details

The disclosure was signed by Surendrakumar Tibrewala in his capacity as Promoter of Fineotex Chemical Limited and submitted on April 06, 2026. The filing was made on behalf of the entire promoter and promoter group as listed in Annexure – A. The communication was directed to the stock exchanges for their records and acknowledgement, in compliance with the annual disclosure requirements under SEBI's Takeover Regulations.